AAV9-based PMM2 gene replacement augments PMM2 expression and improves glycosylation in primary fibroblasts of patients with phosphomannomutase 2 deficiency (PMM2-CDG)
Ming Zhong(University of Utah), Kent Lai(University of Utah)
Cited by 9
Related Papers
The Leloir Pathway of Galactose Metabolism – A Novel Therapeutic Target for Hepatocellular Carcinoma
|Anticancer Research|2016|57
Harnessing the Power of Purple Sweet Potato Color and Myo-Inositol to Treat Classic Galactosemia
|International Journal of Molecular Sciences|2022|8
AAV-based gene replacement reverses Neurexin-2 downregulation in the cerebellum of a mouse model of phosphomannomutase 2 deficiency (PMM2-CDG)
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0